KENOSHA COUNTY, Wis. — Eli Lilly announced Thursday that the Indianapolis-based pharmaceutical giant plans to build off its recent purchase of a manufacturing facility in Kenosha County.

"They're going to be investing over $3 billion in a new plant and they're going to be creating hundreds of good-paying jobs in Kenosha County," said Missy Hughes, the secretary and CEO of the Wisconsin Economic Development Corporation. "It's just really exciting."

Hughes attributed the company's decision to expand in the area to Wisconsin's workforce and its status as a U.S. Regional Tech Hub.

She suggested that even more development there could follow.

"We expect to see companies that are cutting-edge, innovation companies and companies that are working to solve huge problems for our health and healthcare to continue to come to Wisconsin," Hughes said.

The investment will help meet growing demand for injectable products like its diabetes and obesity drugs, Mounjaro and Zepbound.

Those drugs brought in a combined $4.4 billion in sales for Lilly in this year’s third quarter.

The drugmaker plans to start construction of the expansion next year.

Lilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier this year.

Eli Lilly and Co. said Thursday that it has slated more than $23 billion to construct, expand or acquire manufacturing sites worldwide since 2020.

Watch the full interview above.